- Home
- CVKD vs IMCC Comparison
CVKD vs IMCC Comparison
Compare CVKD & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVKD
- IMCC
- Stock Information
- Founded
- CVKD 2022
- IMCC 1980
- Country
- CVKD United States
- IMCC Israel
- Employees
- CVKD N/A
- IMCC N/A
- Industry
- CVKD Medicinal Chemicals and Botanical Products
- IMCC Medicinal Chemicals and Botanical Products
- Sector
- CVKD Health Care
- IMCC Health Care
- Exchange
- CVKD Nasdaq
- IMCC Nasdaq
- Market Cap
- CVKD 17.1M
- IMCC 5.0M
- IPO Year
- CVKD 2023
- IMCC N/A
- Fundamental
- Price
- CVKD $15.24
- IMCC $2.11
- Analyst Decision
- CVKD Strong Buy
- IMCC
- Analyst Count
- CVKD 2
- IMCC 0
- Target Price
- CVKD $52.50
- IMCC N/A
- AVG Volume (30 Days)
- CVKD 59.6K
- IMCC 11.9K
- Earning Date
- CVKD 11-08-2024
- IMCC 11-11-2024
- Dividend Yield
- CVKD N/A
- IMCC N/A
- EPS Growth
- CVKD N/A
- IMCC N/A
- EPS
- CVKD N/A
- IMCC N/A
- Revenue
- CVKD N/A
- IMCC $36,445,402.00
- Revenue This Year
- CVKD N/A
- IMCC $22.59
- Revenue Next Year
- CVKD N/A
- IMCC $20.53
- P/E Ratio
- CVKD N/A
- IMCC N/A
- Revenue Growth
- CVKD N/A
- IMCC N/A
- 52 Week Low
- CVKD $5.40
- IMCC $1.13
- 52 Week High
- CVKD $32.55
- IMCC $8.10
- Technical
- Relative Strength Index (RSI)
- CVKD 60.90
- IMCC 41.06
- Support Level
- CVKD $11.19
- IMCC $2.02
- Resistance Level
- CVKD $15.93
- IMCC $2.15
- Average True Range (ATR)
- CVKD 1.36
- IMCC 0.14
- MACD
- CVKD 0.23
- IMCC -0.01
- Stochastic Oscillator
- CVKD 61.01
- IMCC 19.15
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.